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lymphoblastic leukemia in a child with
Down syndrome bearing a t(2;12)(p12;p13)
involving ETV6 and biallelic IGH@
rearrangements
Carlos A. Tirado*†, David Shabsovich†, Yeun Kim, Peter Traum, Sheeja Pullarkat, Michael Kallen and Nagesh RaoThe original version of this article [1] unfortunately
contained mistakes.
The metaphase FISH studies using the Vysis IGH Dual
Color, Break Apart Rearrangement Probe revealed 1
fusion signal on the normal chromosome 14 correspond-
ing to an intact IGH@ locus, a red signal corresponding to
the 3′ region of the IGH@ locus on the derivative
chromosome 14, and a green signal corresponding to the
5′ region of the IGH@ locus on the derivative chromo-
some 8. This was not described correctly in the results
section of the original manuscript.
Additionally, in the discussion, the reference for the
case bearing the concomitant t(8;14)(q11.2;q32) and
del(12)(p12p13) should be Byatt et al., not Harrison
et al.
Finally, the email of the corresponding author (Carlos
Tirado) should be ctirado@mednet.ucla.edu.
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